CardioNXT Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $10M
Latest Deal Amount
  • Investors
  • 5

CardioNXT General Information

Description

Developer of detection technology designed to detect cardiac arrhythmias. The company's technology offers a platform of products, that allow a better understanding of complex cardiac arrhythmias such as Atrial Fibrillation and deliver targeted therapy to affected areas within the heart, enabling people to adopt arrhythmia therapies in global markets as well as in the underserved emerging markets.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Other Healthcare Services
Primary Office
  • 12011 North Tejon Street
  • Denver, CO 80234
  • United States

CardioNXT Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioNXT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 29-Jul-2019 $10M 000.00 Completed Clinical Trials - General
4. Early Stage VC (Series B) 01-Jun-2017 00.00 00.00 0000 Completed Clinical Trials - General
3. Early Stage VC (Series A1) 31-May-2016 00.00 00.00 000.00 Completed Clinical Trials - General
2. Grant 14-May-2015 $250K $1M Completed Startup
1. Early Stage VC (Series A) 22-Aug-2012 $1M $1M 00.00 Completed Startup
To view CardioNXT’s complete valuation and funding history, request access »

CardioNXT Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 000
Series A1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 6,697,488 $0.001000 6% $0.15 $0.15 1x $0.15 22.91%
To view CardioNXT’s complete cap table history, request access »

CardioNXT Executive Team (4)

Name Title Board Seat Contact Info
Jerome Edwards Chief Executive Officer, President & Co-Founder
Donald Conty JD Chief Financial Officer & General Counsel
Thomas Kurian MD Co-Founder & Chief Medical Officer
James Bullock Chairman
To view CardioNXT’s complete executive team members history, request access »

CardioNXT Board Members (1)

Name Representing Role Since
James Bullock Self Chairman 000 0000
To view CardioNXT’s complete board members history, request access »

CardioNXT Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CardioNXT Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
James Bullock Angel (individual) Minority 000 0000 000000 0
Piedmont Capital Partners Merchant Banking Firm Minority 000 0000 000000 0
William Hawkins Angel (individual) Minority 000 0000 000000 0
Solas BioVentures Venture Capital Minority 000 0000 000000 0
Office of Economic Development and International Trade Government 000 0000 000000 0
To view CardioNXT’s complete investors history, request access »